超声引导下腓肠肌脉冲射频治疗跟痛症的临床疗效及安全性研究

摘要

Objective: Nowadays, there is still no good treatment for plantar heel-pain. We studied whether the radiofrequency treatment (UG-PRF) of the gastrocnemius is safe and effective to relieve plantar heel pain. Methods: In this study, 100 patients with plantar heel pain were randomly divided into UG-PRF group and sham treatment group. We compared two groups at pre-operation (baseline) and 3 or 6 months of post-treatment. Outcome measures included the pain subscale of the Foot Health Status Questionnaire (FHSQ-pain), "first step"pain as measured on a visual analogue scale (VAS- "first-step" pain), the FHSQ-foot function and general foot health, and health related quality of life [using the Short Form-36 questionnaire (SF-36) to assessed]. Results:The results showed the efficacy of UG-PRF in terms of pain management, as reflected by higher FHSQ-pain score (increased by 20.0 (P < 0.0001) and 17.9 (P = 0.001) compared with the sham treatment at 3 and 6 months, respectively) and lower VAS- "first- step" pain (reduced by 26.1 (P < 0.0001) and 14.3 (P = 0.01) compared with the sham group at 3 or 6 months, respectively. The FHSQ-foot function and FHSQ-general foot health were increased by the UG-PRF (P < 0.05, vs sham treatment at 3 or 6 months). The SF-36 physical component score in the sham group was 10.8 (P = 0.042) and 10.4 (P = 0.044) lower than the UG-PRF group at 3 or 6 months, respectively. No severe complications were observed. Conclusions: We conclude that the UG-PRF is both safe and efficacious in managing plantar heel pain.%目的:目前临床仍旧缺乏针对顽固性跟痛症的治疗方案.我们研究在超声引导下腓肠肌脉冲射频治疗(UG-PRF)能否安全有效地缓解跟痛症.方法:这项研究比较UG-PRF组与假手术组治疗100例跟痛症病人.主要评价指标包括:足部健康状态问卷量表 (FHSQ-疼痛评分) 和"第一步"疼痛在视觉模拟量表(visual analogue scale, VAS) 上测量 (VAS-"第一步"疼痛).次要评价指标包括:FHSQ-足部功能和足部健康评分,以及健康调查简表(SF-36)来进行评估.分别在治疗后的第3和6个月评估相关结果.结果:随访中,两组比较,UG-PRF组在3或6个月时,具有更高的FHSQ-疼痛评分[分别比假手术组增加了20.0 (P < 0.0001)和17.9 (P = 0.001)],且具有更低的VAS-"第一步"疼痛评分 [分别为26.1 (P < 0.0001)和14.3 (P = 0.01)].术后第3和第6个月时,UG-PRF组比假手术组,有更高的FHSQ足功能评分和足部健康评分 (P < 0.05).且假手术组的SF-36得分为10.8 (P = 0.042) 和10.4 (P = 0.044),均低于UG-PRF组.两组治疗期间均没有观察到严重的并发症.结论:超声引导下腓肠肌脉冲射频治疗(UG-PRF)能够安全和有效的治疗跟痛症.